FGEN/Astellas approval of roxa in Japan for NDD CKD | Biotech Message Board Posts

Biotech   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  35259 of 35723  at  11/27/2020 7:05:03 AM  by

Biotech_Jim

The following message was updated on 11/27/2020 7:07:08 AM.

FGEN/Astellas approval of roxa in Japan for NDD CKD

 “We are delighted roxadustat is now approved in Japan for adults with anemia of CKD not on dialysis, as it allows even more patients to access this important new treatment option,” said Bernhardt G. Zeiher, M.D., Chief Medical Officer, Astellas. “With its novel mechanism of action and oral administration, we hope roxadustat will alleviate some of the burden associated with anemia of CKD prior to the initiation of dialysis and deliver meaningful improvements in the lives of these patients.”